Immunovant
IMVT
31.77
-0.75
-2.31%
Immunovant
US · IMVT
#1790 by market cap
Listed 2017
31.77
-0.75
-2.31%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Cuts Target Price to $49Market Newswire · 2026/11/13
-
Rating change
J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $50Market Newswire · 2026/8/10
-
Rating change
BofA Securities Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $45Market Newswire · 2026/10/12
-
Rating change
LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $53Market Newswire · 2026/9/26
-
Wells Fargo Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $47Market Newswire · 2026/11/10
-
BofA Securities Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $46Market Newswire · 2026/11/10
-
Rating change
J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $47Market Newswire · 2026/5/27
-
Rating change
LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $53Market Newswire · 2026/7/9
-
Rating change
Guggenheim Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $62Market Newswire · 2026/5/26
-
Rating change
A Quick Look at Today's Ratings for Immunovant(IMVT.US), With a Forecast Between $41 to $66Market Newswire · 2026/8/8
-
Rating change
Truist Financial Maintains Immunovant(IMVT.US) With Hold RatingMarket Newswire · 2026/9/24
-
H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $41Market Newswire · 2026/11/11
-
Rating change
Stifel Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $57Market Newswire · 2026/8/13
-
Rating change
Bernstein Initiates Immunovant(IMVT.US) With Hold Rating, Announces Target Price $37Market Newswire · 2026/9/26
-
Rating change
H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $41Market Newswire · 2026/8/7
-
Rating change
J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $50Market Newswire · 2026/8/4
-
Wells Fargo Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $47Market Newswire · 2026/11/10
-
Rating change
Piper Sandler Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $66Market Newswire · 2026/9/21
-
Rating change
Citi Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $61Market Newswire · 2026/6/30
-
Rating change
J.P. Morgan Sticks to Their Buy Rating for Immunovant (IMVT)TipRanks · 2026/8/10
-
Rating change
H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $40Market Newswire · 2026/5/26
-
Rating change
A Quick Look at Today's Ratings for Immunovant(IMVT.US), With a Forecast Between $40 to $45Market Newswire · 2026/5/22
-
Rating change
LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $45Market Newswire · 2026/5/23
-
Rating change
H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $41Market Newswire · 2026/9/24
-
Rating change
Stifel Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $49Market Newswire · 2026/5/25
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Immunovant discussion 0 comments